QDEL QuidelOrtho Corporation: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
QuidelOrtho management is focusing on extracting post-merger synergies and expanding its diagnostic menu. However, QuidelOrtho faces a debt burden and a post-pandemic decline in revenue. Simultaneously, the company is implementing eco-standards to reduce plastic in its tests. The company's EV/EBITDA ratio over the time series reflects the business valuation dynamics, with this metric currently equal to 9.49.
Analytical breakdowns and data insights for company quidel.com (QDEL)
- stock price and consensus target price:
- company stock capitalization data:
- book value of equity indicators:
- company liabilities and liquidity data:
- financial results and valuation multiples details:
QDEL - Company Net Income|Expected Profit QuidelOrtho|QDEL - Price to Earnings Ratio|Future Price to Earnings QuidelOrtho|QDEL - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization QuidelOrtho Inc.|QDEL - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months QuidelOrtho|QDEL - Earnings per share for the last four quarters|Quarterly EPS earnings growth quidel.com|QDEL - Earnings per share increase in current year|Net earnings per share growth forecast for next year QuidelOrtho
Fundamental company analysis:QuidelOrtho Corp QDEL
The dynamic EV/EBITDA value of QuidelOrtho (QDEL), which has reached 9.49, reflects the enterprise value of the business relative to its operating profit. This metric determines the issuer's resilience to margin compression, which is critical for assessing the new management's ability to stabilize cash flows and ensure organic growth in the post-merger period.
Analysis of competing companies
Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OPKO Health, Inc. (OPK)|CareDx, Inc. (CDNA) - Enterprise Value to EBITDA Multiple|Maravai LifeSciences Holdings, Inc. - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Fulgent Genetics Inc FLGT|Fluidigm - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Cytek Corp CTKB|OSUR: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation XGN|MDXH (MDxHealth) - EV/EBITDA Multiple|Company Value to EBITDA Lucid Diagnostics, Inc. LUCD|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Prenetics Global (PRE)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IMDX (imdxinc.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Trinity Biotech TRIB|prophaselabs.com (PRPH) - Company Value to EBITDA|AIMD - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation CODX (Co-Diagnostics Inc)|HSCS (Heart Test Laboratories Inc.) - Enterprise Value to EBITDA Ratio|BMRA: Enterprise Value to Operating Income Before Depreciation Ratio|CDIO (Cardio Diagnostics Holdings Inc.) - EV/EBITDA Multiple|ONCO: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Virax Biolabs (VRAX)|BJDX - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vermillion AWH|Enterprise Value to EBITDA Multiple Accelerate Diagnostics Inc|CENTOGENE, N.V. - EV/EBITDA Multiple|ENZ (Enzo Biochem, Inc.) - Enterprise Value to Operating Income Before Depreciation|FRES: EV/EBITDA Multiple|Company Value to EBITDA Genetic Technologies Limited (GENE)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 23andMe Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PMD
